With a portfolio of clinical studies that fluctuates year over year depending on the portfolio, resource and cost constraints are a constant issue. Questions such as how many patients will participate in clinical studies? How will the studies be paid for? Will they be managed internally?
Projecting required resources across the portfolio is a difficult proposition. Most pharmaceutical companies use both internal resources and external headcount to manage the clinical workload. The challenge is to objectively and accurately project the internal resource pool that will be required to run studies in the coming years while maximizing available budget.